-
Shanghai copper bottomed out and rebounded, and the trend climbed further in the afternoon
Time of Update: 2022-12-04
In terms of term structure, the copper market maintained a positive arrangement of near low and far high, and the positive price difference between the Shanghai copper 1703 contract and the 1704 contract widened to 210 yuan / ton, indicating that the willingness of forward contracts to rise has increased.
-
Avient Introduces Moisture Resistant Nylon 6 and 66 Reinforced Long Fiber Composites
Time of Update: 2022-11-10
The new series of moisture-resistant nylon filaments have been modified to absorb moisture more slowly “When manufacturers look to quell performance issues by limiting the hygroscopicity of nylon 6 or 66, the only option is lower hygroscopic, higher-cost specialty nylons,” said Eric Wollan, general manager of Avient Long Fiber Technologies.
-
J Autoimmunity: Sex-specific analysis of Behçet's disease reveals higher genetic risk in male patients
Time of Update: 2022-10-19
Results: Genetic association analysis comparing male and female patients with Turkish Behçet disease showed that males in HLA-B/MICA within the HLA region were associated with a significant level of GWAS (rs2848712, OR=1.
-
2021 IMW BCMA CAR-T therapy cilta-cel treatment of MM research results update
Time of Update: 2021-10-02
Research conclusions At a median follow-up of 18 months, cilta-cel achieved early, lasting and deep disease remission in patients with relapsed and refractory MM, and its safety was controllable .
Research conclusions Cilta-cel has achieved early and deep disease remission in MM patients with controllable safety .
-
The State Food and Drug Administration releases 2019 drug review report
Time of Update: 2020-08-06
Drug Review Center accepted a total of 700 applications for registration of 1 type of innovative drug (319 varieties), (the number of varieties of chemical drugs active ingredients, the number of varieties of Chinese medicine and biological products are all counted by the generic name of the drug, the same below), the number of varieties increased by 20.8% compared to 2018.
